Rapid Opioid Countermeasure System (ROCS) / Naloxone Auto-Injector

About Kaléo

Kaléo is a privately held, commercial-stage biotech company specializing in advanced drug-delivery technology, primarily through its proprietary Aerio™ Auto-Injector Platform. The company has a dual focus: partnering with pharmaceutical companies and government agencies to develop custom drug-device combinations, and commercializing its own portfolio of marketed auto-injector products for anaphylaxis and opioid overdose. With a strong foundation in human factors engineering and automated manufacturing, Kaléo is positioned as a trusted partner in the emergency medicine and medical countermeasures sectors, driven by a patient-first philosophy inherited from its founders.

Therapeutic Areas